In vitro co-cultures and CTC-derived xenografts (CDXs) would be required to define the distinct roles of Fas/FasL pathway among CTCs and circulating immune cells and its impact on the tumor-immune crosstalk in the PB of BC patients. The gene discussed is FAS; the disease is breast cancer.